ADMA Biologics Inc (NAS:ADMA)
$ 10.49 0.4 (3.96%) Market Cap: 2.43 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 15.89 GF Score: 65/100

ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 08:30PM GMT
Release Date Price: $2.37 (+5.80%)
Christine Ha

Hi, everyone. Thanks for joining our fireside chat with ADMA Biologics. We have with us today ADMA's CEO, Adam Grossman; and CFO, Brian Lenz. Adam and Brian, thanks for joining us.

Before we start, I need to read a quick disclaimer for the webcast. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representatives. (Operator Instructions)

So Adam, do you want to kick us off and maybe you can give a brief introduction of ADMA for those who may not be familiar with the story?

Adam S. Grossman
ADMA Biologics, Inc. - Co-Founder, President, CEO & Director

Sure. Thank

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot